Herniated Nucleus Pulposus
10
0
0
4
Key Insights
Highlights
Success Rate
80% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
10.0%
1 terminated out of 10 trials
80.0%
-6.5% vs benchmark
10%
1 trials in Phase 3/4
25%
1 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (10)
Lumbar Operatively Inserted PerQdisc Artificial Implant Following Nuclectomy 3
The Course of Hip Flexion Weakness Following LLIF or ALIF
ViBone in Cervical and Lumbar Spine Fusion
Effectiveness of Conventional Therapy Plus Pulsed-Radiofrequency for Herniated Nucleus Pulposus
RHINE™ Cervical Disc Clinical Study: A Prospective Observational Study for Patients Requiring 1-2 Level C-spine Surgery
Learning Curve, Outcome Parameters, and MRI Assessment of Disc Evacuation After Transforaminal Percutaneous Endoscopic Lumbar Discectomy
The Efficacy of Continuous Cold-Therapy on Postoperative Pain and Narcotics Use Following Spinal Fusion
Impact of Local Steroid Application in Extreme Lateral Lumbar Interbody Fusion
Retest-reliability and At-home-assessment Feasibility of the 5R-STS
A Clinical Comparison in Cervical Epidural Pressure Changes Between Midline and Paramedian Approaches